Explore more publications!
Florida Health Daily
Got News to Share?

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on September 17, 2025

MET Florida Partners With Southern Sassafras Marketing To Strengthen Healthcare IT And Branding
September 17, 2025

MET Florida Partners With Southern Sassafras Marketing To Strengthen Healthcare IT And Branding

Indeterminate EIN Presswire
Palm Beach Orthopaedic Institute Introduces Smart Knee Implant
September 17, 2025

Palm Beach Orthopaedic Institute Introduces Smart Knee Implant

Indeterminate EIN Presswire
Rising Diabetes Rates in Americans with Disabilities Fuel Demand for Improvements in Care
September 17, 2025

Rising Diabetes Rates in Americans with Disabilities Fuel Demand for Improvements in Care

Indeterminate EIN Presswire
Feather In Her Cap Award Nominations Open. Organization Adds New Award to Recognize Animal Health ‘Champions of Women’
September 17, 2025

Feather In Her Cap Award Nominations Open. Organization Adds New Award to Recognize Animal Health ‘Champions of Women’

Indeterminate EIN Presswire
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
September 17, 2025

Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

Indeterminate GlobeNewswire
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
September 17, 2025

Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering

Indeterminate GlobeNewswire
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
September 17, 2025

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

Indeterminate GlobeNewswire
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
September 17, 2025

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation

Indeterminate GlobeNewswire
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
September 17, 2025

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

Indeterminate GlobeNewswire
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
September 17, 2025

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

Indeterminate GlobeNewswire
NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1
September 17, 2025

NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1

Indeterminate GlobeNewswire
Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
September 17, 2025

Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM

Indeterminate GlobeNewswire
CooperCompanies Announces Expanded Share Repurchase Program
September 17, 2025

CooperCompanies Announces Expanded Share Repurchase Program

Indeterminate GlobeNewswire
Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares
September 17, 2025

Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares

Indeterminate GlobeNewswire
Vaxart Appoints W. Mark Watson as Lead Independent Director
September 17, 2025

Vaxart Appoints W. Mark Watson as Lead Independent Director

Indeterminate GlobeNewswire
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
September 17, 2025

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Joint Commission and Coalition for Health AI (CHAI) Release Initial Guidance to Support Responsible AI Adoption Across U.S. Health Systems
September 17, 2025

Joint Commission and Coalition for Health AI (CHAI) Release Initial Guidance to Support Responsible AI Adoption Across U.S. Health Systems

Indeterminate GlobeNewswire
Buying Guide to the Top & Most Effective Beetroot Supplements 2025: Pills and Powder By MushCanyon
September 17, 2025

Buying Guide to the Top & Most Effective Beetroot Supplements 2025: Pills and Powder By MushCanyon

Indeterminate GlobeNewswire
VELA Medical USA Highlights Projected U.S. Ophthalmology Workforce Shortage by 2035
September 17, 2025

VELA Medical USA Highlights Projected U.S. Ophthalmology Workforce Shortage by 2035

Indeterminate EIN Presswire
Are Women on the Frontline of Antimicrobial Resistance?
September 17, 2025

Are Women on the Frontline of Antimicrobial Resistance?

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions